Author Correction: Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors (Nature Immunology, (2023), 24, 8, (1345-1357), 10.1038/s41590-023-01543-9)

0Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Correction to: Nature Immunology. Published online 3 July 2023. In the version of this article initially published, Ashmitaa Logandha Ramamoorthy Premlal (Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA), who contributed to the bioinformatic analysis of TCR genes, was missing from the author list. In Fig. 4e, the red dotted key reading “0.3” appeared originally as “3”. In the Competing interests statement, Bjoern Peters was not listed as an inventor on patents related to tumor-specific TCRs. The HTML and PDF versions of the article are now updated with the changes.

Cite

CITATION STYLE

APA

Brightman, S. E., Becker, A., Thota, R. R., Naradikian, M. S., Chihab, L., Zavala, K. S., … Schoenberger, S. P. (2023, August 1). Author Correction: Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors (Nature Immunology, (2023), 24, 8, (1345-1357), 10.1038/s41590-023-01543-9). Nature Immunology. Nature Research. https://doi.org/10.1038/s41590-023-01591-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free